First-in-Class VS Me-Too Launch Differences and the Role of Content, Hyperpersonalization, and Technology with Frank Dolan, Founder and CEO of ARSENAL

How are first-in-class launches distinct from me-too launches?
Why is it harder to access HCPs and launch products successfully?
What are the opportunities for 1st-time launchers to have successful launches despite reduced access to HCPs?
Will pharma encourage or discourage peer-to-peer scientific exchange online?

To answer these questions, Bozidar is joined by Frank Dolan, Founder, and CEO of ARSENAL

They cover:

[ 01:48 ] - When COVID happened, it broke the traditional commercial pharma launch model. The main reason is that customers' behaviors and preferences for consuming information have fundamentally changed. That is the challenge pharma faces, and no matter how experienced and educated marketers may be, they will have to adapt
[ 03:28 ] - When launching a first-in-class product, there is no infrastructure set in place. So you have to lay the foundation for the brand to roll over. That means changing the landscape with new tools, helping providers think about treating things differently, and addressing the concerns of the payers and patients
[ 15:31 ] - Salesforce or field presence size matters less today. So if you have a highly efficient field team with great digital competency, leveraging virtual interactions, they can appeal to many people. The market has changed, and getting the right message to the right customer at the right time brings a huge opportunity to be very intentional about the different channels to which you are communicating those messages
[ 20:50 ] - The killer content that makes a difference in pharma should be customized. Personalization is the leading component toward best-in-class content. Then using this content in various formats, like video, is a huge opportunity. And the last piece here is that content should be delivered from a credible source

If you want to learn more about leading a successful pharma marketing campaign in the US, tune in to this episode of Pharma Launch Secrets, a Podcast by Evermed.

Subscribe here:

Google Podcasts: https://bit.ly/3PUds6T
Apple: https://apple.co/3micGmF
Spotify: https://spoti.fi/3M78XCC
RSS: https://bit.ly/3wTksIm
Instructions on how to rate and review Pharma Launch Secrets can be found here

And connect with Frank here:

LinkedIn: https://www.linkedin.com/in/frankfdolan/
Website: https://arsenal-advisors.com/

About The Show:

“Pharma Launch Secrets” is a podcast by Evermed and hosted by Bozidar Jovicevic, where we host direct, actionable conversations with world-leading pharma launch experts and help you stay up-to-date with the latest trends and strategies to help you launch your product successfully.